Accretive Capital Partners

Accretive Capital Partners is a private investment firm focused on value investing, direct secondary private equity, co-investments, and small public company investments. Available public sources describe it as an investment manager rather than an operating biotechnology, pharmaceutical, or healthcare company. The firm appears to have operated through Accretive Capital Management as manager and has filed SEC Form D and beneficial ownership reports. While some biographies mention exposure to life sciences investments, there is no evidence that Accretive Capital Partners itself develops therapeutics, diagnostics, or healthcare products. As a result, it should be classified as a financial sponsor/investment entity, not a life sciences operating company.